Chuck Royce's VNDA Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 13,213 shares of Vanda Pharmaceuticals Inc. (VNDA) worth $64,876, representing 0.00% of the portfolio. First purchased in 2019-Q3, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in VNDA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 119,329 shares. Largest reduction occurred in Q2 2022, reducing 163,564 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Vanda Pharmaceuticals (VNDA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vanda Pharmaceuticals (VNDA) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +13,213 | New Buy | 13,213 | $4.91 |
| Q1 2023 | -12,821 | Sold Out | 0 | $0.00 |
| Q4 2022 | -10,334 | Reduce 44.63% | 12,821 | $7.39 |
| Q3 2022 | -52,908 | Reduce 69.56% | 23,155 | $9.89 |
| Q2 2022 | -163,564 | Reduce 68.26% | 76,063 | $10.90 |
| Q1 2022 | +119,329 | Add 99.19% | 239,627 | $11.31 |
| Q4 2021 | -5,119 | Reduce 4.08% | 120,298 | $15.69 |
| Q3 2021 | -7,994 | Reduce 5.99% | 125,417 | $17.14 |
| Q2 2021 | -3,347 | Reduce 2.45% | 133,411 | $21.51 |
| Q1 2021 | +3,369 | Add 2.53% | 136,758 | $15.02 |
| Q4 2020 | +63,841 | Add 91.79% | 133,389 | $13.14 |
| Q3 2020 | +35,342 | Add 103.32% | 69,548 | $9.66 |
| Q2 2020 | +5,919 | Add 20.92% | 34,206 | $11.43 |
| Q1 2020 | +808 | Add 2.94% | 28,287 | $10.36 |
| Q4 2019 | +13,193 | Add 92.35% | 27,479 | $16.41 |
| Q3 2019 | +14,286 | New Buy | 14,286 | $13.30 |
Chuck Royce's Vanda Pharmaceuticals Investment FAQs
Chuck Royce first purchased Vanda Pharmaceuticals Inc. (VNDA) in Q3 2019, acquiring 14,286 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Vanda Pharmaceuticals Inc. (VNDA) for 16 quarters since Q3 2019.
Chuck Royce's largest addition to Vanda Pharmaceuticals Inc. (VNDA) was in Q1 2022, adding 239,627 shares worth $2.71 M.
According to the latest 13F filing for Q3 2026, Chuck Royce's firm, Royce & Associates Lp, owns 13,213 shares of Vanda Pharmaceuticals Inc. (VNDA), valued at approximately $64,876.
As of the Q3 2026 filing, Vanda Pharmaceuticals Inc. (VNDA) represents approximately 0.00% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Vanda Pharmaceuticals Inc. (VNDA) was 239,627 shares, as reported at the end of Q1 2022.